CD4 and neoplasm: In this study, we demonstrated that mice cured of tumors by combination therapy, consisting of the transfer of ex vivo—expanded CD4+ T cells after irradiation and Treg depletion, successfully rejected the challenge of MCA205 tumor cells 90 days after the first inoculation of MCA205 cells (Fig 4B).